SCANCRIT - August 30, 2017 - By Thomas D
"There’s not much left of poor MONA. We’ve written on unnecessary O2 treatment before, ie the AVOID trial. And now, one of the large RCTs on the subject is out. The DETO2X-SWEDEHEART investigators (love the acronym) have published their findings in NEJM: Routine oxygen therapy gave no advantage over breathing ambient air..."